Parallax Volatility Advisers
INO icon

Parallax Volatility Advisers’s Inovio Pharmaceuticals INO Stock Holding History

Parallax Volatility Advisers’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5
Closed -$2K – 3095
2020
Q2 		$2K Buy
+5
New +$803 ﹤0.01% 2654
2018
Q1 		– Sell
-1,029
Closed -$51K – 3218
2017
Q4 		$51K Buy
+1,029
New +$63.8K ﹤0.01% 3218

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parallax Volatility Advisers's INO Position: Q3 2020 in Review

Parallax Volatility Advisers sold out of Inovio Pharmaceuticals (INO) in Q3 2020, closing a stake of 5 shares — an estimated $2K sold.

Parallax Volatility Advisers first reported a position in INO in Q4 2017 and held it in 2 quarters. The position peaked at $51K in Q4 2017. 212 funds tracked by Wall St. Rank hold INO as of Q3 2020.

  • Parallax Volatility Advisers reported no remaining Inovio Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 5 Inovio Pharmaceuticals shares in Q3 2020, an estimated $2K.
  • Parallax Volatility Advisers first reported a position in Inovio Pharmaceuticals in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Inovio Pharmaceuticals position peaked at $51K in Q4 2017.
  • 212 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2020.

Based on Parallax Volatility Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.